Ottavia Viganò

Female gender is associated with long COVID syndrome: a prospective cohort study

Francesca Bai, Daniele Tomasoni, Camilla Falcinella et al. · Clinical Microbiology and Infection · 2021 · 663 citations · Full text

Social Sciences, Endocrinology, Infectious Diseases +13

Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers

Laurenzia Ferraris, Ottavia Viganò, Anna Maria Peri et al. · Journal of Antimicrobial Chemotherapy · 2012 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Abacavir Hypersensitivity Reaction after Switching from the Twice-Daily to the Once-Daily Formulation

Cristina Gervasoni, Ottavia Viganò, Erika Grinelli et al. · AIDS Patient Care and STDs · 2007 · 16 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens

Daniel González de Requena, Stefano Bonora, Ottavia Viganò et al. · Journal of Antimicrobial Chemotherapy · 2010 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease

Antonella d’Arminio Monforte, Alessandro Tavelli, Francesca Bai et al. · International Journal of Infectious Diseases · 2020 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +16